
    
      PRIMARY OBJECTIVES:

      I. Evaluate the impact of breast cancer pathways on patient experience, burden of decision
      making and quality of life in tertiary cancer center and community oncology practice.

      II. Identify modifiable factors that affect provider adoption of breast cancer pathways in
      tertiary cancer center and community oncology practice.

      OUTLINE: Participants are assigned to 1 of 2 groups.

      GROUP I: Participants receive standard chemotherapy educational materials. Participants also
      complete surveys over approximately 22 minutes at the time of first chemotherapy infusion,
      and approximately 8 weeks after first chemotherapy infusion.

      GROUP II: Participants receive personalized information about their cancer, treatment, and
      side effects. Participants also complete surveys over approximately 22 minutes at the time of
      first chemotherapy infusion, and approximately 8 weeks after first chemotherapy infusion.
    
  